About kyle.mcneir@artifactorie.com

This author has not yet filled in any details.
So far kyle.mcneir@artifactorie.com has created 27 blog entries.

PHASE Scientific Donates More than 2,000 INDICAID COVID-19 Tests to Atlanta Public Schools Back to School Bash

(ATLANTA, GA) – July 27, 2022 PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company, announced that it has donated 2,000 of its FDA EUA-approved INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) to Atlanta Public Schools for […]

PHASE Scientific Donates More than 2,000 INDICAID COVID-19 Tests to Atlanta Public Schools Back to School Bash2022-08-02T02:25:13+05:00

PHASE Scientific Donates 4,000+ INDICAID COVID-19 Tests to The People Concern

The People Concern, a Leading Provider of Homelessness Services, to Bolster Los Angeles Testing Initiatives

 

(Garden Grove, CA) – July 8, 2022 PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company, announced that it has donated 4,300 of its approved INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) to […]

PHASE Scientific Donates 4,000+ INDICAID COVID-19 Tests to The People Concern2022-08-03T21:08:47+05:00

Here’s How Long Some Popular At-Home Virus Test Kits Actually Last, According To The FDA

It may not always be clear when the kits will expire.

Americans were recently offered another chance to order free at-home coronavirus testing kits through the Postal Service. But since federal and state agencies have extended the shelf lives of several brands of tests, it may not always be clear when the free kits, […]

Here’s How Long Some Popular At-Home Virus Test Kits Actually Last, According To The FDA2022-07-12T03:01:59+05:00

PHASE Scientific donates 600 of its INDICAID® COVID-19 Rapid Antigen At-Home Tests for CancerCon in Minneapolis June 9-12

PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that it has donated 600 of its approved INDICAID® COVID-19 2-pack Rapid Antigen At-Home Test (INDICAID® OTC) to Stupid Cancer, Inc., a 501(c)3 nonprofit leader in the adolescent and young adult cancer movement for their […]

PHASE Scientific donates 600 of its INDICAID® COVID-19 Rapid Antigen At-Home Tests for CancerCon in Minneapolis June 9-122022-07-11T22:21:54+05:00

INDICAID® COVID-19 Rapid Antigen Test Detects Omicron Variant B.1.1.529 & Sub-Variant BA.2 (B.1.1.529.2)

Updated May 24TH, 2022

Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen Test.

An independent evaluation by the National Institutes of Health (NIH) RADx Variant Task Force has determined that the INDICAID® […]

INDICAID® COVID-19 Rapid Antigen Test Detects Omicron Variant B.1.1.529 & Sub-Variant BA.2 (B.1.1.529.2)2022-05-25T19:27:45+05:00

PHASE Scientific Americas Launches Online Shop for At-Home COVID-19 Tests

INDICAID® OTC COVID-19 Rapid Antigen Tests Now Available for Direct Consumer Purchase

GARDEN GROVE, CA, April 25, 2022 — PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that its EUA approved INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) is now available for […]

PHASE Scientific Americas Launches Online Shop for At-Home COVID-19 Tests2022-04-25T23:56:39+05:00

INDICAID’S Omicron Variant Update

INDICAID’s Omicron BA.2 Variant Update

April 04, 2022

Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen test. A sub-variant of Omicron designated BA.2 (B.1.1529.2) was detected in the U.S. in January 2022, and the Centers […]

INDICAID’S Omicron Variant Update2022-04-13T20:57:40+05:00

Facing the “Stealth Omicron” Sub-variant’s Dominance Head-On

No New Surges Means Good Preventive Care

Despite its pervasiveness and spikes in Asia and Europe, the Covid-19 Omicron BA.2—dubbed the Stealth Omicron by the World Health Organization (WHO)—has appeared to have lost its choke-hold on the U.S. It’s stealthy no more, Carl Zimmer remarks in his New York Times piece.

Omicron BA.2 […]

Facing the “Stealth Omicron” Sub-variant’s Dominance Head-On2022-03-29T23:27:16+05:00
Go to Top